Prescription analysis and cost of antidepressant drugs in major depressive disorder outpatients at the tertiary care hospital of Pakistan: a prospective approach

References

• World Health Organization (WHO) [Internet]. 2002. Promoting rational use of medicines: core components. WHO Policy Perspectives on Medicines, Geneva: WHO; [cited 2020 Oct 01]. Available from: https://apps.who.int/iris/handle/10665/67438
   Google Scholar
• World Health Organization (WHO) [Internet]. 2012. The pursuit of responsible use of medicines: sharing and learning from country experiences. Geneva: WHO; [cited 2020 Oct 01]. Available from: https://apps.who.int/iris/handle/10665/75828
   Google Scholar
• Sisay M, Mengistu G, Molla B, et al. Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study. BMC Health Serv Res. 2017;17(1):161–164.
   PubMedGoogle Scholar
• Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC Public Health. 2016;16(1):724–727.
   PubMedGoogle Scholar
• Tejus A, Saxena SK, Dwivedi AK, et al. Analysis of the prescription pattern of psychotropics in an outpatient department of a general hospital psychiatry unit. Med J Armed Forces India. 2020 [cited 2020 Oct 02]. [3]. doi:https://doi.org/10.1016/j.mjafi.2020.03.006.
   Google Scholar
• Ronaldson A, Elton L, Jayakumar S, et al. Severe mental illness and health service utilisation for nonpsychiatric medical disorders: a systematic review and meta-analysis. PLoS Med. 2020;17(9):e1003284.
   PubMedGoogle Scholar
• Luo Y, Kataoka Y, Ostinelli EG, et al. National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis. Front Psychiatry. 2020;11:1–11.
   PubMedGoogle Scholar
• Prince M, Patel V, Saxena S, et al. No health without mental health. Lancet. 2007;370(9590):859–877.
   PubMed Web of Science ®Google Scholar
• Marasine NR, Sankhi S, Lamichhane R, et al. Use of antidepressants among patients diagnosed with depression: a scoping review. Biomed Res Int. 2021;2021:6699028.
   PubMedGoogle Scholar
• World Health Organization (WHO) [Internet]. 2021. Depression. Geneva: WHO; [cited 2021 Jan 01]. Available from: https://www.who.int/news-room/fact-sheets/detail/depression
   Google Scholar
• Wikipedia [Internet]. Suicide in Pakistan. 2015. [cited 2021 Jan 02]. Available from: https://en.wikipedia.org/wiki/Suicide_in_Pakistan
   Google Scholar
• Islam B, Shahriar I, Jannat T. Prescribing pattern of antidepressant drugs in two teaching hospitals in Bangladesh. Mediscope. 2019;6(2):53–58.
   Google Scholar
• Ogbo FA, Mathsyaraja S, Koti RK, et al. The burden of depressive disorders in South Asia, 1990–2016: findings from the global burden of disease study. BMC Psychiatry. 2018;18(1):333–344.
   PubMedGoogle Scholar
• Muhammad-Gadit AA, Mugford G, Heo M. Prevalence of depression among households in three capital cities of Pakistan: need to revise the mental health policy. PLoS ONE. 2007;2(2):e209.
   PubMedGoogle Scholar
• Gadit A, Vahidy A. Mental health morbidity pattern in Pakistan. Jour Coll Physicians Surg Pak. 1999;9:362–365.
   Google Scholar
• The World Bank [Internet]. 2018. Current expenditure (% of GDP)-Pakistan. The World Bank, [cited 2021 Jan 02]. Available from: https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=PK
   Google Scholar
• Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357–1366.
   PubMed Web of Science ®Google Scholar
• Mahmood S, Hussain S, Ur-Rehman T, et al. Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future. Curr Med Res Opin. 2019;35(1):51–61.
   PubMed Web of Science ®Google Scholar
• Kamran S, Saqlain M, Khan Z, et al. Cost analysis of registered brands of oral antidepressant drugs in Pakistan: a descriptive analysis. Expert Rev Pharmacoecon Outcomes Res. 2020;20(5):473–479.
   PubMed Web of Science ®Google Scholar
• Drummond MF, Sculpher MJ, Claxton K. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford: Oxford University Press; 2015.
   Google Scholar
• Lady Reading Hospital (LRH), Peshawar [Internet]. 2021. [cited 2021 Jan 02]. Available from: https://www.lrh.edu.pk/pages/about-us.html
   Google Scholar
• Wikipedia [Internet]. 2021. Peshawar. [cited 2021 Jan 03]. Available from: https://en.wikipedia.org/wiki/Peshawar
   Google Scholar
• Asian Development Bank (ADB) [Internet]. 2021. Poverty data: Pakistan. cited 2021 Jan 03 Available from: https://www.adb.org/countries/pakistan/poverty
   Google Scholar
• Atif M, Sarwar MR, Azeem M, et al. Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan. BMC Health Serv Res. 2016;16(1):684–688.
   PubMedGoogle Scholar
• Khan M, Ullah R, Khan A, et al. Assessment of prescriptions in the endocrinology department of a tertiary care hospital in Pakistan using World Health Organization guidelines. Adv Prev Med. 2020;2020(2020):1–6.
   Google Scholar
• Drug Regulatory Authority of Pakistan (DRAP) [Internet]. 2018. National essential medicines list. Pakistan: DRAP; [cited 2021 Jan 05]. Available from: https://www.dra.gov.pk/Home/Download?ImageName=Final%20Design%20NEML%20OCTOBER%202018.pdf
   Google Scholar
• World Health Organization (WHO) [Internet]. 2021. WHO/Anatomical Therapeutic Classification System (WHO/ATC). ATC/DDD Index. Oslo: WHO; cited 2021 Jan 05. https://www.whocc.no/atc_ddd_index
   Google Scholar
• FOREX.pk [Internet]. 2021. cited 2021 Jun 27]. Available from: https://www.forex.pk
   Google Scholar
• PharmaGuide 4.2.2.6 [Internet]. 2021. PharmaGuide publishing company. [cited 2021 Jan 07]. Available from: https://pharmaguide.en.uptodown.com/android
   Google Scholar
• Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230–234.
   PubMed Web of Science ®Google Scholar
• Rankin A, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2018;9(9):CD008165.
   PubMedGoogle Scholar
• Akl OA, El Mahalli AA, Elkahky AA, et al. WHO/INRUD drug use indicators at primary healthcare centers in Alexandria, Egypt. J Taibah Univ Med Sci. 2014;9(1):54–64.
   Google Scholar
• Pugazhenthan T, Ravichandran UA, Tamilselvan T, et al. Evaluation of drug use pattern in central leprosy teaching and research institute as a tool to promote rational prescribing. Indian J Lepr. 2017;89:99e107.
   Google Scholar
• Dutta S, Kaul V, Beg MA, et al. A psychotropic drug use study among depression patients attending private psychiatric practitioners of Dehradun, Uttarakhand. Int J Med Sci Publ Health. 2015;4(5):634e638.
   Google Scholar
• Chen C, Si TM, Xiang YT, et al. Prevalence and prescription of antidepressants in depression with somatic comorbidity in Asia: the research on east Asian psychotropic prescription patterns study. Chin Med J (Engl). 2015;128(7):853–858.
   PubMedGoogle Scholar
• Bastaki K, El Anbari M, Ghuloum S, et al. Prescription pattern of antidepressants and the potential for personalized medicine in the Qatari population. J Pers Med. 2021;11(5):406–411.
   PubMedGoogle Scholar
• Chee KY, Tripathi A, Avasthi A, et al. International study on antidepressant prescription pattern at 40 major psychiatric institutions and hospitals in Asia: a 10 year comparison study. Asia Pac Psychiatry. 2015;7(4):366–374.
   PubMedGoogle Scholar
• Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry. 2001;3(1):22–27.
   PubMedGoogle Scholar
• Puspitasari IM, Sinuraya RK, Rahayu C, et al. Medication profile and treatment cost estimation among outpatients with schizophrenia, bipolar disorder, depression, and anxiety disorders in Indonesia. Neuropsychiatr Dis Treat. 2020;16:815–828.
   PubMed Web of Science ®Google Scholar
• Rabeea SA, Merchant HA, Khan MU, et al. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19. Daru. 2021;29(1):217–221.
   PubMed Web of Science ®Google Scholar
• Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44.
   PubMedGoogle Scholar
• Okumura Y, Higuchi T. Cost of depression among adults in Japan. Prim Care Companion CNS Disord. 2011;13(3): PCC.10m01082. doi:https://doi.org/10.4088/PCC.10m01082.
   Google Scholar
• Patel B, Patel K, Patel M. Antidepressant drugs: evaluation of price variation. Int J Basic Clin Pharmacol. 2015;4:432–437.
   Google Scholar
• Chaithra KN, Laxminarayana K. Cost variation analysis study of oral anti-depressant drugs available in India. Int J Basic Clin Pharmacol. 2017;6(4):973–977.
   Google Scholar
• Khadka A, Manandhar P, Katuwal N, et al. Prescription analysis for variation in the cost of different brands of same medicine for the treatment of depression at a tertiary hospital of Nepal. BJHS. 2020;5(2):1006–1010.
   Google Scholar
• Tripathi RK, Singh S. Cost variation analysis among different antidepressant drugs used to treat major depressive disorder. JPABS. 2019;6(2):51–54.
   Google Scholar